The prognosis of LGG patients with high PROS1 levels was poor in women, age > 40 years, 1p/19q non-codeletion, SD&PD, and astrocytoma subgroups (Fig. 6A–E). This evidence concerns the gene PROS1 and astrocytoma (excluding glioblastoma).